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Aims and method In-patients on mental health wards are commonly prescribed
hypnotics for the long-term management of disturbed sleep. Specific sleep disorders
remain underdiagnosed and effective behavioural interventions are underused. We
developed a suite of three educational interventions (a video, poster and handbook)
about sleep, sleep disorders, the safe prescribing of hypnotics and use of
psychological strategies (sleep hygiene and cognitive–behavioural therapy for
insomnia, CBTi) using co-design and multiprofessional stakeholder involvement. This
controlled before-and-after study evaluated the effectiveness of these interventions
across seven in-patient psychiatric wards, examining their impact on hypnotic
prescribing rates and staff confidence scores (data collected by retrospective drug
chart analysis and survey respectively).
Results A marked reduction was seen in the percentage of patients prescribed
hypnotics on in-patient prescription charts (−24%), with a 41% reduction in the
number of hypnotics administered per patient (mean reduction −1.142
administrations/patient).
Clinical implications These simple educational strategies about the causes and
treatment of insomnia can reduce hypnotic prescribing rates and increase staff
confidence in both the medical and psychological management of insomnia.
Keywords Sleep; hypnotics; benzodiazepines; deprescribing; implementation
science.
Sleep and mental health are inextricably linked, with asso-
ciations between abnormal sleep and depression,1 bipolar
disorder,2 schizophrenia,3 autism spectrum disorders,4
attention-deficit hyperactivity disorder (ADHD)5 and relapse
rates in addiction.6 Adequate duration and timing of sleep
are essential for maintaining good physical and mental
health.7–9 Sleep disturbance has been associated with a
two- to threefold increase in risk of psychiatric in-patient
admission10 and of suicide.11 The psychiatric in-patient set-
ting in itself can be detrimental to sleep quality.12 As many
as two-thirds of in-patients on psychiatric wards experience
insomnia13 and poor sleep is a predictor for psychiatric
readmission.14
If left untreated, sleep disorders (Table 1) such as
insomnia, narcolepsy, circadian rhythm disorders, parasom-
nias and restless legs syndrome can have deleterious effects
on cardiovascular, metabolic and mental health, and some
are linked to an increase in mortality.15–17 ‘Poor sleep’ is
not in its own right a diagnosis.18 This evidence–practice
gap contributes to delays in diagnosis and treatment,19 an
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overprescribing of hypnotic medication,20 has a negative
impact on recovery from psychiatric disorders and can
cause misattribution of symptoms.21 Teaching on distinct
sleep disorders and effective behavioural interventions for
insomnia is generally lacking in UK undergraduate medical
curricula.22 In practice, an increase in prescribing rates,
mortality and drug spend indicates a culture of inappropri-
ate prescribing, suggesting that there is also a paucity of
training about sleep disorders at graduate level.23
Hypnotics are widely prescribed for adult psychiatric
in-patients suffering from poor sleep.24 They can be effective
and necessary for acute insomnia,25 but if insomnia persists
the benefits of hypnotics may wane while the risk of side-
effects increases.26 Hypnotics have the potential to worsen out-
comes for sleep apnoea, anxiety, cognitive function and depres-
sion,27 and pose a significant risk of dependence and harm with
long-term use.28 Hypnotics are commonly overprescribed:29 a
2015 survey of English general practice populations described
inappropriate hypnotic prescribing as a public health problem,
estimating that over a quarter of a million people take hyp-
notic medication beyond licensed timescales.30
Hypnotic medication should only be considered after
appropriate assessment and after, or in combination with,
psychological therapies such as cognitive–behavioural therapy
for insomnia (CBTi).31 The deprescribing (cessation of
inappropriate medication)32 of hypnotic medication is consid-
ered problematic.33 A lack of institutional structures, inad-
equate resources, and the attitudes and practice of more
senior clinicians have been cited as barriers to this process.34
At present, compliance with evidence-based care in
sleep management is suboptimal.35 Increasingly, pharmaco-
logical agents are chosen over non-pharmacological treat-
ments.36 Disturbances to sleep are multifactorial in
nature.37 Although causal components can be tied to the
patient’s psychiatric diagnosis, underlying physical health
condition or a distinct sleep disorder, there is a need for
improved resourcing and greater awareness of assessment
and treatment strategies to aid practitioners in managing
insomnia38 and, more broadly, improving sleep on in-patient
units. Barriers to implementation include: workload/time
pressures, a lack of resources, a lack of authority to change
practice, a workplace culture resistant to change and a lack
of support from other staff members.39 There are modifiable
behavioural factors that can markedly improve sleep.40
In in-patient settings, staff-related factors include reducing
ward noise and overnight nursing observations, optimising
the patient’s bedroom for sleep and increasing staff aware-
ness of sleep management.41 Patient-related factors include
reducing caffeine, alcohol and nicotine consumption,42 set-
ting a routine wake up time, introducing a wind-down period
prior to attempting sleep and avoiding prolonged periods in
bed while awake.43 Strategic factors include educational
meetings, printed educational materials, local opinion lea-
ders, revising professional roles and practice facilitation.
Multifaceted, tailored strategies may be more effective at
creating sustained change in practice.44
This study examines whether improving awareness of
sleep, insomnia and behavioural sleep interventions among
clinicians supports the deprescribing of hypnotics. The impact
of a simple, online educational package on the prescribing pat-
terns on in-patient mental health units was evaluated.
Method
Design
A co-design approach45 was employed to develop a package
of educational interventions designed to be generalisable
Table 1 Overview of specific sleep disorders
Sleep disorder Nature Treatment
Insomnia disorder Difficulty initiating and/or maintaining sleep, with daytime
impact
Cognitive–behavioural therapy for insomnia (CBT-I)
Hypnotics
Narcolepsy Neurological condition causing symptoms of excessive
sleepiness and sleep attacks
Refer to specialist
Parasomnia Includes: sleepwalking, confusional arousals, night terrors,





Disorder of the sleep–wake cycle (e.g. advanced/delayed
sleep phase syndrome, free running circadian rhythm
disorder)




Characterised by an unpleasant aching/creeping/crawling
sensation in the legs resulting in the irresistible urge to move;
often worse at night or at rest; may cause limb twitching
Precipitating factor for insomnia
General practitioner management initially, with RLS-UK for
patient support
Lifestyle: avoid stimulants in the evening; quit smoking;
exercise; good sleep habits
Medicines: dopamine antagonists (pramipexole, ropinirole,




More prevalent in men over 50 who are overweight,
particularly in those with neck circumference >43 cm (>17
inches)
Alcohol and sedative medications also risk factors
Consider in those who have daytime sleepiness and a
witnessed snore
Refer to specialist for sleep study for diagnosis
First line: continuous positive airway pressure (CPAP)
device
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to practitioners across all care settings. The package, part of
the Smarter Sleep educational materials (available from
https://www.cntw.nhs.uk/resource-library/smarter-sleep/),
comprised
• an overview video: a 9 min overview of normal sleep,
specific sleep disorders, hypnotics and psychological
therapies for insomnia
• a poster: to prompt nursing staff towards simple sleep
interventions instead of hypnotic administration
• a handbook: a detailed review of sleep, causes of sleep
disturbance and basic principles of CBTi.
These interventions were introduced to wards, and emails
were sent each month as reminders that the interventions
were active. Acute and rehabilitation wards for both male
and female patients on one hospital site were eligible to par-
ticipate. Wards on other sites within the trust (other than
the control ward) were excluded.
Development of the intervention
The development, embedding and evaluation of these
interventions can be mapped to the knowledge-to-action
(KTA) framework46 (Fig. 1). This framework involves two
phases – knowledge creation and the action cycle – which
are interlinked and feed dynamically between each other.
Knowledge creation
Represented by a ‘knowledge funnel’, this consists of knowl-
edge inquiry, synthesis and products/tools. This process
encapsulates primary literature (knowledge inquiry) and
secondary literature (synthesis), which are condensed
down to produce ‘third-generation knowledge’ in the form
of products/tools (decision aids, guidelines and pathways).
The action cycle
This part of the KTA framework represents the application
of the knowledge creation process. It involves identifying
the problem (the overprescribing of hypnotics) and then
selecting the knowledge required for the intervention. We
did this through literature review.47,48 Knowledge was then
adapted to the local context through discussions with ward
managers, and barriers to knowledge use were identified
(time, ward pressures, resource availability). The interven-
tions were tailored and implemented in the form of a
video, poster and handbook, and knowledge use was
monitored through the survey completion data and hypnotic
prescribing rate data. Outcomes were evaluated using these
data and case studies from implementation of the interven-
tions. Knowledge use is being sustained through the embed-
ding of interventions into everyday practice, and the hosting





























1.   Video
–   Hypnotic
     prescribing data
–  Survey data
–  Case studies
–   Share
     interventions
–  Encourage sleep
    reviews
–  Identify ‘sleep
    champions’
–   Staff time
–   Ward pressures
–   Resource availability
Evaluate
outcomes
2.   Poster
3.   Handbook
–   Survey completion rate
–   Hypnotic prescribing data
Fig. 1 The knowledge-to-action (KTA) framework (based on Graham et al46).
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Hypnotic prescribing and administration rates
A controlled before-and-after approach was taken to assess
the impact of the interventions. Point prevalence data
were collected via retrospective drug chart analysis over 2
full months (September 2019 and December 2019), with 2
months between for interventions to become embedded.
These data consisted of a count of the number of active
hypnotic prescriptions written on the drug charts of each
ward during these periods. Data were also collected on the
number of hypnotic administrations (i.e. individual doses)
that took place on each pilot ward over this same periods.
All doses in these time periods were counted, even if a
patient was prescribed multiple hypnotic agents. These out-
comes were relevant in evaluating the impact of the inter-
ventions on practice.
For example, seven doses administered against a pre-
scription of ‘zopiclone 7.5 mg at night when required’ would
count as one active prescription and seven total administra-
tions. Data were analysed using descriptive statistics.
Pre- and post-intervention survey
The survey was undertaken entirely online. A pre-
intervention survey was emailed to all participants prior to
watching the video, along with a link to the video and elec-
tronic copies of the resources. This was followed by a post-
intervention survey 10–12 weeks later (Table 2). The survey
assessed baseline knowledge and attitudes towards current
sleep management (pre-intervention survey) and then mea-
sured any changes that had taken place in the knowledge and
attitudes of individuals over the intervention period (post-
intervention survey). These outcomes were relevant in
assessing whether the interventions had an impact on staff
knowledge and behaviours, even if this impact was not
enough to change prescribing and administration rates on
the wards.
Participants
The package of educational interventions was designed by a
stakeholder group consisting of hospital pharmacists (n = 8),
primary care pharmacists (n = 4), a neurologist with specialist
interest in sleep (n = 1) and consultant psychiatrists (n = 3).
Stakeholders were recruited through local networks and
selected for their knowledge and experience in insomnia,
hypnotics or local practice. A patient and public involvement
group was also consulted to consider which messages they
would want to ensure were communicated to healthcare
staff caring for them. Extensive consultation in the form of
draft videos and resources shared via email ensured that
these interventions would be generalisable across all care
settings. A draft video was also shown at a regional pharmacy
conference and feedback was collected on the content and
quality, to be integrated into the final version.
The resulting interventions were introduced on
in-patient wards (n = 7) in one hospital and compared
against a control ward. A geographically distant hospital
within the same trust was selected for the control ward, to
mitigate the risk of migration of practice if staff cross-
covered pilot and control wards.
Ethics
All participants gave their informed consent for inclusion
before they participated in the study. The study was con-
ducted in accordance with the Declaration of Helsinki, and
the protocol was approved by the Ethics Committee of
Newcastle University Faculty of Medical Sciences. The project
was also registered with the research department at Cumbria,
Northumberland, Tyne and Wear NHS Foundation Trust.
Standards
The SQUIRE statement was used as a scaffold in the writing
of this paper.49
All wards received the same level of resources for imple-
mentation of the intervention. Variation in levels of staff
engagement with the interventions may have led to variation
between wards, but the interventions themselves were standar-
dised across all pilot wards. The control (comparator) ward had
no interventions delivered, but staff were informed that data
would be collected to allow for comparison, and interventions
made available after the evaluation phase had been completed.
Results
Hypnotic prescribing and administration rates
A decrease in the number of administrations occurred on all
wards except one, which was a psychiatric intensive care
Table 2 Comparison of the questions in the pre- and post-
intervention surveys
Pre-intervention survey Post-intervention survey
1. Please indicate your job role 1. Please indicate your job role
2. How confident do you feel
using mediation to help patients
sleep (/5)
2. How confident do you now feel
using mediation to help patients
sleep (/5)
3. Please rank the following
sleeping tablets from 1 ‘most







3. Please rank the following
sleeping tablets from 1 ‘should be
most commonly used’ to 5






4. Please explain why you have
ranked the above sleeping
tablets in the order you have
listed
4. Please explain why you have
ranked the above sleeping tablets
in the order you have listed
5. In your own words, please
describe how you would
manage a patient reporting poor
sleep
5. How confident do you now feel
about using psychological
strategies such as cognitive–
behavioural therapy for insomnia
(CBTi) to help patients sleep?
6. How confident do you
personally feel about using
psychological strategies such as
cognitive–behavioural therapy
for insomnia (CBTi) to help
patients sleep?
6. Has your approach to
managing a patient who is
reporting poor sleep changed
since before you did this
training? If so, how?
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unit (PICU) treating patients with more challenging beha-
viours (Fig. 2). Overall, there was a mean reduction of 41%
in the number of hypnotic administrations per patient
across the pilot site. This compares with the control site,
which showed a 37% increase in the administrations of hyp-
notics per patient on the control ward (Table 3).
A decrease in the percentage of patients prescribed
hypnotics occurred on 71% of the pilot wards (Fig. 3). The
PICU and female acute wards did not show a decrease,
however. Overall, there was a mean reduction of 24% in the
percentage of patients prescribed hypnotics on the pilot
site. This compares with the control ward (a mixed-gender
rehabilitation ward), which showed no change.
Pre- and post-intervention survey
A total of 251 staff were invited to participate in the survey.
Non-participation reasons included a lack of time, leave of
absence and self-perceived adequate pre-existing knowledge
in this subject area. Survey response data were collected on
the pre-intervention questionnaire (n = 85) and post-
intervention questionnaire (n = 45) (total n = 131). Total
respondents for both surveys comprised: nurses (pre-
intervention n = 27; post-intervention n = 13); junior doctors
(pre, 7; post, 1); specialty trainees (pre, 6; post, 3); consul-
tants (pre, 3; post, 2); pharmacists (pre, 12; post, 12); phar-
macy technicians (pre, 6; post, 4); psychologists (pre, 7;
post, 2); and ‘other’ (pre, 17; post, 8). Two respondents did
not complete the question about job role.
Before and after the intervention, respondents were
asked to rate their confidence (on a Likert scale from 1,
‘not confident’ to 5, ‘extremely confident’) in using medica-
tion versus psychological strategies to help patients sleep.
An increase was seen in confidence scores for using medica-
tion and for using psychological strategies to help patients
sleep (Table 4).
The intervention prompted a change in the order in
which hypnotics were considered (Table 5) for sleep
management. Melatonin rose in ranking, whereas prometha-
zine fell.
When asked pre-intervention to comment on their
rationale behind the ranking decisions they had made, 87%
of respondents mentioned that their ranking of the listed
medications was based on what they had ‘seen in practice’
or ‘heard of the most’, i.e. choices were being informed by
existing practice on the wards that staff worked. Only 9%
of respondents mentioned anything about knowledge of
drugs in their response, and no respondents made reference
to the evidence base, cost-effectiveness or risk–benefit. For
example,
‘I picked the medication that I had heard of used within the
service I work. Patients are more frequently prescribed pro-
methazine and zopiclone, promethazine is usually offered
first. Melatonin I believe is non formulary so is used less
regularly. Temazepam is used rarely. I have never heard of
zolpidem before.’ (Foundation Year 1 doctor)
Asked the same question post-intervention, only 13% of
respondents still mentioned in their responses that their
choices were being informed by experience of practice,
whereas 76% mentioned the evidence base, cost-effectiveness
and/or risk–benefit in their responses. For example,
‘Melatonin is licensed in my client group for insomnia.
Evidence base supports the use of Z-drugs and benzodiaze-
pines for short term use in insomnia and Z-drugs have a
slightly more favourable side-effect profile in terms of long-
term dependency. There is little evidence to support the
use of sedating antihistamines for insomnia.’ (Advanced
Pharmacist Practitioner)
Discussion
Hypnotic prescribing and administration rates
Among staff working on the in-patient units studied, knowl-
edge about the mechanism of action of hypnotic medications
and different sleep disorders was limited and informed by
previous practice, not the evidence base. After a short educa-
tional video about sleep disorders and hypnotics, the hyp-
notic prescribing rates decreased by 24% and the
administration rates fell by 41% compared with the control
ward. There was also a difference in which medications
were used as hypnotics, with promethazine use being
reduced. Staff described a better understanding of sleep
and the different available therapies for sleep disorders
after the intervention.
An increase in hypnotics issued was seen on the PICU
despite the implementation of the educational interventions
(Table 2). This may be due to the nature of the patients on
this ward, who are more likely to have challenging beha-








































































Fig. 2 Average number of recorded administrations of hypnotics per patient pre- and post-educational interventions across eight mental health
in-patient wards. Rehab, rehabilitation; PICU, psychiatric intensive care unit.
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psychological therapies compared with patients admitted to
acute and rehabilitation wards.
Pre- and post-intervention survey
Self-rated confidence scores show a larger improvement in
the mean score in relation to medication than in the mean
score for psychological strategies for improving sleep.
Further support and training may be needed to help staff
feel confident in psychological management. Alternatively,
this might suggest that, owing to the often acute nature of
the in-patient setting, hypnotics are deemed to be of greater
utility than psychological strategies in the care of patients
struggling with sleep and/or anxiety.
The table ranking the order in which hypnotics were
considered (Table 5) shows convergence of practice towards
the evidence base. Zolpidem is non-formulary in this geo-
graphical area, which is likely to be the reason for it being
lowest ranked. Promethazine has fallen in ranking, which
is likely to be because the educational package highlighted
its weak evidence base and high side-effect profile.
Melatonin rose in ranking, possibly due to its favourable
side-effect profile and the fact that it is an endogenous hor-
mone involved in regulation of the circadian rhythm. It does,
however, have a short half-life and so its use in sleep disor-
ders may be limited,50 as was highlighted in the educational
package.
An increase in the evidence-based language used when
rationalising the rank order of hypnotics suggests that this
intervention went some way towards closing the evidence–
practice gap in management of poor sleep, as end-user feed-
back illustrates.
End-user feedback
Doctors found these resources useful for instigating positive
change in relation to hypnotic prescribing, reviewing the
clinical need and reducing doses where appropriate:
‘Patients were on hypnotics for weeks and weeks and weeks
and then stopped immediately at discharge. This is bad prac-
tice, and leaves a mess for both GPs [general practitioners]
and the patients. These interventions created a change in cul-
ture so that the mindset for patients prescribed hypnotics is
now to reduce them during the in-patient stay wherever
appropriate.’ (Specialty trainee)
Nursing staff found these resources helpful in offering alter-
native solutions to sleep disturbances, other than adminis-
tering hypnotic medication:
‘I feel like, after watching the video, we started to encourage
patients to use non-pharmacological methods more. This
demonstrated that patients were often showing drug seeking
behaviours, as they would often then go to sleep without
needing hypnotics.’ (Ward manager)
The video was viewed favourably by staff and shone a light
on a field of practice that is often overlooked:
‘Excellent video, extremely important field that is greatly
underestimated, but is pivotal in a patient’s physical, mental
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Generalisability
The presence of the pharmacy team on all wards enabled the
proliferation of the intervention among other staff groups.
Rotation of nursing staff between wards enabled migration
of practice to spread engagement with the interventions
across wards. Some wards (n = 2) were involved in the
SleepWell Project,51 which may have motivated staff to
engage with further work on sleep, but the impact of
SleepWell in relation to this study is unclear. The above
aspects may not exist in other settings.
Limitations
There were several limitations to the study. No data were
gathered on which of the interventions was felt to be the
most effective, as the intervention package was conceptua-
lised as a whole. The evaluation period was short, owing to
the limited time span available within the context of the
funding. There were fewer responses to the post-
intervention survey than to the pre-intervention survey, as
pre-intervention responses were gathered immediately
before accessing the intervention. Post-intervention
responses were gathered 10–12 weeks later, to allow time
for a change in practice to occur. A shorter interval may
have resulted in a lower attrition rate, but seen a smaller
change in prescribing and administration rates. Completing
the post-intervention survey straight after the resources
were accessed may have increased responses but would
have allowed less time for reflection. Introducing a prize
raffle for completion of the post-intervention survey may
also have increased responses.
The control ward was selected because of its geograph-
ical distance from the intervention wards to prevent migra-
tion of practice. During the course of this study the ward was
planned for closure, so admitted fewer and fewer patients,
leading to a lower number of patients in this group.
Future work
Future work could examine the nuances of uptake and bene-
fit between interventions. It might also be valuable to evalu-
ate whether the reduction in inappropriate hypnotic
prescriptions is sustained over time. If it is not sustained,
measuring how long this change lasts and investigating bar-
riers and enablers for maintaining a change in evidence-
based practice would be worthy of future investigation.
Further work could also look at the feasibility and uptake
of these interventions in primary care and examine barriers
and enablers to the delivery of online educational interven-















































Male acute Male acute Control
Pre-intervention Post-intervention
Fig. 3 Percentage of patients prescribed hypnotics per ward pre- and post-educational interventions across eight mental health in-patients wards.
Rehab, rehabilitation; PICU, psychiatric intensive care unit.
Table 4 Self-rated confidence scoresa before and after educational intervention
Before intervention (n = 86) After intervention (n = 45) Actual difference Percentage difference
Item ‘Using medication to help patients sleep’
Mean score 2.77 3.71 +0.94 +18.8%
Item ‘Using psychological strategies to help patients sleep’
Mean score 2.40 3.18 +0.78 +15.6%
a. Rated on a scale of 0–5, where 0 indicates no confidence and 5 indicates very confident.
Table 5 Average rank order of hypnotics for prescribing,
first choice to last choice, before and after educa-
tional intervention
Before intervention
(n = 86) After intervention (n = 45)
1 Zopiclone 1 Zopiclone (no change)
2 Promethazine 2 Melatonin (more favourable choice)
3 Temazepam 3 Temazepam (no change)
4 Melatonin 4 Promethazine (less favourable choice)
5 Zolpidem 5 Zolpidem (no change)
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